Dr. Adrienne Duff:

I intend to be as exact as possible on the questions the Deputy has asked. As I said at the outset, MedLab has been accredited by INAB to ISO 15189 standard since 2011. In order to confirm its accreditation on an annual basis, INAB carries out on-site assessments with consultant histopathology, specifically in relation to cyto-screening.

To directly answer the questions the Deputy asked about our communications as part of the scoping inquiry, in November 2016, MedLab emailed us about information regarding recruitment of a cyto-screener and it intended to locate that cyto-screener in the Manchester office. As we said in our opening statement, we should have followed up more robustly at that stage on that information that was provided.

On 8 February this year, Dr. Scally sent to me a copy of that email which we received from MedLab at the time with the specific-----